Cell Line : NCI-H1693
Cellosaurus Index : CVCL_1488
Cellosaurus ID : NCI-H1693
GDSC1 Name
, GDSC2 Name
: NCI-H1693
CTRP2 Name
: NCIH1693
CCLE Name
: NCIH1693_LUNG
Cancer Type : lung
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| NCI-H1693 | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | 123138 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H1693 | 123829 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H1693 | 150412 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H1693 | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | 5-azacytidine | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H1693 | 5-Fluorouracil | GDSC1,GDSC2 | 0.0200 | 32.0000 |
|
| NCI-H1693 | 50869 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H1693 | 615590 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H1693 | 630600 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H1693 | 667880 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H1693 | 720427 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H1693 | 729189 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H1693 | 741909 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H1693 | 743380 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H1693 | 765771 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H1693 | 776928 | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H1693 | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | A-366 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | AA-COCF3 | CTRP2 | 0.0010 | 17.0000 |
|
| NCI-H1693 | ABT737 | GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H1693 | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | Acetalax | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H1693 | AEW541 | CCLE | 0.0025 | 8.0000 |
|
| NCI-H1693 | Afatinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | AGI-6780 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | AGK-2 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| NCI-H1693 | AKT inhibitor VIII | GDSC1 | 0.0100 | 10.2400 |
|
| NCI-H1693 | Alectinib | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H1693 | Alisertib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H1693 | Alpelisib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | alpha-lipoic acid | GDSC2 | 0.1211 | 121.0000 |
|
| NCI-H1693 | alvocidib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H1693 | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | Amuvatinib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | AR-42 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H1693 | AS601245 | GDSC1 | 0.0312 | 8.0000 |
|
| NCI-H1693 | AS605240 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | ascorbate (vitamin C) | GDSC2 | 2.0011 | 2000.0000 |
|
| NCI-H1693 | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | AT13148 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | AT13387 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | AT7867 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | austocystin D | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H1693 | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | avicin D | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | avrainvillamide | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | Axitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| NCI-H1693 | AZD1208 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | AZD1332 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H1693 | AZD2014 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H1693 | AZD4547 | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| NCI-H1693 | AZD5153 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | AZD5438 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | AZD5991 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H1693 | AZD6482 | GDSC1 | 0.0195 | 5.1200 |
|
| NCI-H1693 | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | AZD7762 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H1693 | AZD8055 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | AZD8186 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H1693 | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Bax channel blocker | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | BAY-61-3606 | GDSC1 | 0.0312 | 8.0000 |
|
| NCI-H1693 | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | BAY-MPS-combo 2 (paclitaxel 1 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| NCI-H1693 | BAY-MPS-combo-1 (paclitaxel 5 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| NCI-H1693 | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| NCI-H1693 | BCL-LZH-4 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BDF00022089a | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H1693 | BDILV000379a | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H1693 | BDOCA000347a | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H1693 | BDP-00009066 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | Belinostat | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BEN | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H1693 | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Bexarotene | GDSC1 | 0.0312 | 8.0000 |
|
| NCI-H1693 | BI-2536 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | BIBR-1532 | GDSC2,CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H1693 | Bicalutamide | GDSC1 | 0.0040 | 10.0000 |
|
| NCI-H1693 | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | BIX02189 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | Bleomycin | GDSC1,GDSC2 | 0.0020 | 64.0000 |
|
| NCI-H1693 | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | Bleomycin (50 uM) | GDSC1,GDSC2 | 0.0400 | 50.0000 |
|
| NCI-H1693 | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BMS-345541 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BMS-536924 | GDSC1,GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H1693 | BMS-754807 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | Bortezomib | GDSC2 | 0.0000 | 0.0200 |
|
| NCI-H1693 | Bosutinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BPD-00008900 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H1693 | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | BRD-A86708339 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K03536150 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H1693 | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| NCI-H1693 | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K34222889 | CTRP2 | 0.0017 | 57.0000 |
|
| NCI-H1693 | BRD-K35604418 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H1693 | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K42260513 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K50799972 | CTRP2 | 0.0020 | 17.0000 |
|
| NCI-H1693 | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K51831558 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K55473186 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| NCI-H1693 | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-K90370028 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| NCI-H1693 | BRD-K99006945 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD-M00053801 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | BRD4132 | CTRP2 | 0.0049 | 80.0000 |
|
| NCI-H1693 | BRD55319 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H1693 | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H1693 | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Bromosporine | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H1693 | Bryostatin 1 | GDSC1 | 0.0000 | 0.0080 |
|
| NCI-H1693 | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | BX795 | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H1693 | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Cabozantinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H1693 | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| NCI-H1693 | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| NCI-H1693 | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H1693 | Carmustine | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H1693 | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | CAY10603 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | CBB-1007 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | CCT-018159 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| NCI-H1693 | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| NCI-H1693 | CD-437 | CTRP2 | 0.0011 | 18.0000 |
|
| NCI-H1693 | CDK9_5038 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H1693 | CDK9_5576 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | Cediranib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| NCI-H1693 | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| NCI-H1693 | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H1693 | CHIR-99021 | GDSC1,CTRP2 | 0.0024 | 80.0000 |
|
| NCI-H1693 | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| NCI-H1693 | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Cisplatin | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| NCI-H1693 | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | COL-3 | CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H1693 | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H1693 | CP724714 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | CPI-637 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | Crizotinib | GDSC2,CCLE | 0.0010 | 10.0000 |
|
| NCI-H1693 | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H1693 | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | CT7033-2 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | CUDC-101 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H1693 | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H1693 | CX-5461 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | Cyclophosphamide | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | Cytarabine | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H1693 | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | Dabrafenib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Dacarbazine | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Dacinostat | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H1693 | Dactinomycin | GDSC2 | 0.0000 | 0.8000 |
|
| NCI-H1693 | Dactolisib | GDSC1,GDSC2,CTRP2 | 0.0003 | 17.0000 |
|
| NCI-H1693 | Daporinad | GDSC1,CTRP2 | 0.0001 | 2.0000 |
|
| NCI-H1693 | Dasatinib | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H1693 | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H1693 | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | Dihydrorotenone | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H1693 | Dinaciclib | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H1693 | DMOG | GDSC1 | 15.6250 | 4000.0000 |
|
| NCI-H1693 | Docetaxel | GDSC1,GDSC2,CTRP2 | 0.0000 | 66.0000 |
|
| NCI-H1693 | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H1693 | Doramapimod | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Doxorubicin | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H1693 | Eg5_9814 | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H1693 | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | Elephantin | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H1693 | Elesclomol | GDSC1 | 0.0008 | 0.2000 |
|
| NCI-H1693 | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Embelin | GDSC1 | 0.1250 | 32.0000 |
|
| NCI-H1693 | Entinostat | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | Enzastaurin | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | Epirubicin | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H1693 | Epothilone B | GDSC1 | 0.0001 | 0.0320 |
|
| NCI-H1693 | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | ERK_2440 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | ERK_6604 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | Erlotinib | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| NCI-H1693 | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H1693 | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| NCI-H1693 | Etoposide | GDSC1,CTRP2 | 0.0009 | 28.0000 |
|
| NCI-H1693 | Fedratinib | GDSC1,CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H1693 | FH535 | GDSC1 | 0.1250 | 32.0000 |
|
| NCI-H1693 | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Fludarabine | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H1693 | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H1693 | FMK | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | Foretinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | FR-180204 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H1693 | FTI-277 | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H1693 | Fulvestrant | GDSC2 | 0.0010 | 10.0000 |
|
| NCI-H1693 | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| NCI-H1693 | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | Gallibiscoquinazole | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H1693 | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | Gefitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Gemcitabine | GDSC1,GDSC2,CTRP2 | 0.0001 | 33.0000 |
|
| NCI-H1693 | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | glutathione | GDSC2 | 0.6403 | 640.0000 |
|
| NCI-H1693 | GMX-1778 | CTRP2 | 0.0000 | 0.3000 |
|
| NCI-H1693 | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| NCI-H1693 | GSK-LSD1 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H1693 | GSK-LSD1-2HCl | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H1693 | GSK1059615 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | GSK1070916 | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H1693 | GSK1904529A | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| NCI-H1693 | GSK2110183B | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H1693 | GSK2256098C | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H1693 | GSK2276186C | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | GSK2636771 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | GSK269962A | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H1693 | GSK2801 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | GSK2830371 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | GSK2830371A | GDSC2 | 0.0030 | 10.0000 |
|
| NCI-H1693 | GSK3337463A | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | GSK343 | GDSC2 | 0.0010 | 10.0000 |
|
| NCI-H1693 | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | GSK429286A | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | GSK626616AC | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H1693 | GSK650394 | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H1693 | GSK690693 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | GW-2580 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H1693 | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H1693 | HBX-41108 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H1693 | HKMTI-1-005 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | I-BET-762 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | I-BET151 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | IAP_5620 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | Ibrutinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | ICL-SIRT078 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | Idelalisib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | IGF1R_3801 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| NCI-H1693 | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | IOX2 | GDSC1 | 0.0004 | 0.1000 |
|
| NCI-H1693 | IPA-3 | GDSC1 | 0.1250 | 32.0000 |
|
| NCI-H1693 | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | IRAK4_4710 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | Irinotecan | GDSC2,CCLE | 0.0025 | 10.0000 |
|
| NCI-H1693 | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| NCI-H1693 | istradefylline | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H1693 | JAK_8517 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | JAK1_8709 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | JNK-9L | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H1693 | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H1693 | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H1693 | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H1693 | JQ1 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | JQ12 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H1693 | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | JW-74 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | KIN001-236 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | KIN001-244 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | KIN001-260 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | KIN001-266 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | KIN001-270 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H1693 | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H1693 | KU-55933 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | KU-60019 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | L-685458 | CTRP2,CCLE | 0.0011 | 37.0000 |
|
| NCI-H1693 | L-Oxonoreleagnine | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H1693 | Lapatinib | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| NCI-H1693 | LBW242 | CCLE | 0.0025 | 8.0000 |
|
| NCI-H1693 | LCL161 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | LE-135 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| NCI-H1693 | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H1693 | LFM-A13 | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H1693 | LGK974 | GDSC2 | 0.0050 | 10.0000 |
|
| NCI-H1693 | Linifanib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Linsitinib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | LMB_AB1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | LMB_AB2 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | LMB_AB3 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | LMP744 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H1693 | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H1693 | LRRK2-IN-1 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Luminespib | GDSC1,GDSC2 | 0.0003 | 1.0000 |
|
| NCI-H1693 | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | LY2109761 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| NCI-H1693 | Masitinib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | Methotrexate | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 |
|
| NCI-H1693 | MG-132 | GDSC2,CTRP2 | 0.0006 | 20.0000 |
|
| NCI-H1693 | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | MI-2 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Midostaurin | GDSC1 | 0.0020 | 0.5120 |
|
| NCI-H1693 | MIM1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | MIRA-1 | GDSC2,CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H1693 | Mirin | GDSC1,GDSC2 | 0.1001 | 100.0000 |
|
| NCI-H1693 | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H1693 | Mitomycin-C | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H1693 | Mitoxantrone | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H1693 | MK-1775 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | MK-2206 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H1693 | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H1693 | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H1693 | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H1693 | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H1693 | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H1693 | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H1693 | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | MLN2480 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H1693 | MPS-1-IN-1 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | Mycophenolic acid | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | N-acetyl cysteine | GDSC2 | 2.0011 | 2000.0000 |
|
| NCI-H1693 | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | N25720-51-A1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | N27922-53-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | N29087-69-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | N30652-18-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| NCI-H1693 | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | Navitoclax | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H1693 | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H1693 | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | necrosulfonamide | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Nelarabine | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | NG-25 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | Nilotinib | GDSC1,GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| NCI-H1693 | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| NCI-H1693 | NPK76-II-72-1 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H1693 | NSC-207895 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | NSC-87877 | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H1693 | NSC23766 | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H1693 | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | NSC632839 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H1693 | Nutlin-3a | GDSC1,GDSC2,CTRP2,CCLE | 0.0025 | 150.0000 |
|
| NCI-H1693 | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | NVP-ADW742 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | NVP-BHG712 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | NVP-TAE684 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| NCI-H1693 | O-6-benzylguanine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Obatoclax Mesylate | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | Olaparib | GDSC1,GDSC2,CTRP2 | 0.0045 | 150.0000 |
|
| NCI-H1693 | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Omipalisib | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H1693 | OSI-027 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | OSI-930 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H1693 | OSU-03012 | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H1693 | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H1693 | Oxaliplatin | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | PAC-1 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | Paclitaxel | GDSC2,CTRP2,CCLE | 0.0000 | 66.0000 |
|
| NCI-H1693 | PAK_5339 | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H1693 | Palbociclib | GDSC1,GDSC2,CCLE | 0.0025 | 10.0000 |
|
| NCI-H1693 | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | Panobinostat | CCLE | 0.0025 | 8.0000 |
|
| NCI-H1693 | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H1693 | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H1693 | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H1693 | Parthenolide | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Pazopanib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | PBD-288 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H1693 | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | PD 153035 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | PD0325901 | GDSC1,GDSC2,CCLE | 0.0003 | 8.0000 |
|
| NCI-H1693 | PD173074 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| NCI-H1693 | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| NCI-H1693 | Pelitinib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | Pevonedistat | GDSC1,GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H1693 | PF-3758309 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | PF-4708671 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | PF-4800567 hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | PF-562271 | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H1693 | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | PF-750 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H1693 | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | PFI3 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | PHA-665752 | CCLE | 0.0025 | 8.0000 |
|
| NCI-H1693 | PHA-793887 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Phenformin | GDSC1 | 15.6250 | 4000.0000 |
|
| NCI-H1693 | phloretin | CTRP2 | 0.0180 | 590.0000 |
|
| NCI-H1693 | PI-103 | GDSC1,CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H1693 | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | Pictilisib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| NCI-H1693 | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | PIK-93 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | Piperlongumine | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | PLX-4720 | GDSC1,GDSC2,CTRP2,CCLE | 0.0010 | 33.0000 |
|
| NCI-H1693 | Podophyllotoxin bromide | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H1693 | POMHEX | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | Ponatinib | GDSC1 | 0.0020 | 0.5120 |
|
| NCI-H1693 | PRIMA-1MET | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H1693 | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H1693 | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | QL-X-138 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | QL-XII-47 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | QS11 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | Quizartinib | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H1693 | R428 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | RAF265 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| NCI-H1693 | Rapamycin | GDSC2,CTRP2 | 0.0000 | 33.0000 |
|
| NCI-H1693 | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Remodelin | GDSC2 | 0.0500 | 50.0000 |
|
| NCI-H1693 | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H1693 | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H1693 | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | RO4929097 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Romidepsin | GDSC2 | 0.0000 | 0.0100 |
|
| NCI-H1693 | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| NCI-H1693 | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H1693 | Ruxolitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | salermide | CTRP2 | 0.0120 | 400.0000 |
|
| NCI-H1693 | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| NCI-H1693 | Sapitinib | GDSC2 | 0.0050 | 10.0000 |
|
| NCI-H1693 | Saracatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| NCI-H1693 | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H1693 | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H1693 | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | SB216763 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | SB505124 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | SB52334 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H1693 | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H1693 | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H1693 | Schweinfurthin A | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H1693 | Selisistat | GDSC1,CTRP2 | 0.0024 | 80.0000 |
|
| NCI-H1693 | Selumetinib | GDSC1,GDSC2,CTRP2,CCLE | 0.0025 | 270.0000 |
|
| NCI-H1693 | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H1693 | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H1693 | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H1693 | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H1693 | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H1693 | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| NCI-H1693 | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 83.0000 |
|
| NCI-H1693 | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Sepantronium bromide | GDSC1,GDSC2,CTRP2 | 0.0000 | 10.0000 |
|
| NCI-H1693 | Serdemetan | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | SGC-CBP30 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H1693 | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| NCI-H1693 | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Shikonin | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H1693 | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | Sinularin | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H1693 | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H1693 | skepinone-L | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | SL0101 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | SN-38 | GDSC1,GDSC2,CTRP2 | 0.0000 | 1.3000 |
|
| NCI-H1693 | SNX-2112 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H1693 | Sorafenib | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| NCI-H1693 | sotrastaurin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| NCI-H1693 | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | STF-62247 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | SU11274 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | SZ4TA2 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | T-5345967 | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H1693 | T0901317 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | TAF1_5496 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | TAK-715 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | Tamoxifen | GDSC1,GDSC2,CTRP2 | 0.0030 | 100.0000 |
|
| NCI-H1693 | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Tanespimycin | GDSC1,GDSC2,CTRP2,CCLE | 0.0010 | 33.0000 |
|
| NCI-H1693 | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H1693 | Taselisib | GDSC2 | 0.0040 | 10.0000 |
|
| NCI-H1693 | Telomerase Inhibitor IX | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | Temozolomide | GDSC1,GDSC2,CTRP2 | 0.0041 | 66.0000 |
|
| NCI-H1693 | Temsirolimus | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| NCI-H1693 | Teniposide | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H1693 | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Thalidomide | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Thapsigargin | GDSC1 | 0.0020 | 0.5120 |
|
| NCI-H1693 | THR-101 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | THR-102 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | THR-103 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | THZ-2-102-1 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H1693 | THZ-2-49 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | Tipifarnib | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H1693 | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | tivantinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Tivozanib | GDSC1 | 0.0005 | 0.1280 |
|
| NCI-H1693 | TKI258 | CCLE | 0.0025 | 8.0000 |
|
| NCI-H1693 | TL-1-85 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | TL-2-105 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | Topotecan | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| NCI-H1693 | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H1693 | TPCA-1 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Trametinib | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H1693 | Tretinoin | GDSC1,CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H1693 | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| NCI-H1693 | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0051 | 83.0000 |
|
| NCI-H1693 | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | triptolide | CTRP2 | 0.0000 | 0.3000 |
|
| NCI-H1693 | Tubastatin A | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | TW 37 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | Ulixertinib | GDSC2 | 0.0020 | 10.0000 |
|
| NCI-H1693 | ULK1_4989 | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H1693 | UMI-77 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | UNC0321 | CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H1693 | UNC0379 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | UNC0638 | GDSC1,GDSC2,CTRP2 | 0.0010 | 40.0000 |
|
| NCI-H1693 | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 17.0000 |
|
| NCI-H1693 | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| NCI-H1693 | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| NCI-H1693 | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | VAF-347 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| NCI-H1693 | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H1693 | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | Veliparib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H1693 | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H1693 | Vinblastine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H1693 | Vincristine | GDSC2,CTRP2 | 0.0030 | 130.0000 |
|
| NCI-H1693 | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H1693 | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | VNLG-124 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H1693 | Vorinostat | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | VSP34_8731 | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H1693 | VTP-A | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H1693 | VTP-B | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H1693 | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | VX-11e | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| NCI-H1693 | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H1693 | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | WHI-P97 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | Wnt-C59 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | WZ3105 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | WZ4002 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | XAV939 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H1693 | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H1693 | XMD13-2 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | XMD14-99 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | XMD15-27 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H1693 | Y-39983 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | YK-4-279 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H1693 | YM201636 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H1693 | ZD-6474 | CCLE | 0.0025 | 8.0000 |
|
| NCI-H1693 | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| NCI-H1693 | Zibotentan | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H1693 | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H1693 | ZM447439 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H1693 | Zoledronate | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H1693 | ZSTK474 | GDSC1 | 0.0200 | 5.1200 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC